Eutilex Co., Ltd.

ALPITERO

Pharmaceutical preparations for the treatment of cancer cells; living cells for medical or clinical use; pharmaceutical preparations for activating cellular function; biological preparations for the treatment of immune system related disorders; biological preparations for the treatment of cancer; pharmaceutical preparations for immunity adjustment; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for tumor treatment; vaccines; pharmaceutical preparations for the treatment of cancers with T cells; pharmaceutical preparations for the treatment of cancers with CAR-T cells;

COSTIM

Chemical analysis; Chemistry consultation; Chemical research; Technology research in the field of medical apparatus and instruments; Consulting services for others in the field of design, planning, and implementation project management of scientific research; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Biotechnology research; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics biotechnology; Biological research; Biochemical analysis; Biochemical research; Medical or scientific research relating to modifying genes; Advisory services relating to modifying genes for scientific purposes; Research and development of genetically modified animal; Research and development of genetically modified plants; Research in the field of cosmetics; pharmaceutical research and development; Research and development of food dietary supplements; Research and development of vaccines and medicines; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Medical research; Research and development of new products;

EUTILEX

Pharmaceutical preparations for the treatment of cells; living cells for veterinary purposes; stem cells for veterinary purposes; living cells for medical purposes; T cells for medical purposes; cellular function activating agents for medical purposes; milk sugar for pharmaceutical purposes; pharmaceutical preparations for health care, namely immune boosters; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; vaccines; pharmaceutical preparations for wounds; reagents for measurement of HBs antibody; antibodies for veterinary purposes; antibodies for medical purposes; biological tissue cultures for veterinary purposes; biological tissue cultures for medical purposes; bacterial preparations for medical purposes; vascular grafts living tissue; microorganisms for medical purposes; medical and surgical plasters;Color is not claimed as a feature of the mark.;

GIPICA

Pharmaceutical preparations for the treatment of cancer cells; Cells for medical or clinical use; Pharmaceutical preparations for activating cellular function; Biological preparations for the treatment of immune system related disorders; Biological preparations for the treatment of cancer; Pharmaceutical preparations for immunity adjustment; Pharmaceutical preparations for regulating the immune system; Pharmaceutical preparations for tumor treatment; Vaccines; Pharmaceutical preparations for the treatment of cancers with T cells; Pharmaceutical preparations for the treatment of cancers with CAR-T cells;Product development in the field of cell therapy; biomedical research services; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; product development, namely, biologics development; biological research and analysis; consultancy in the field of analysis of biology sequence processing for medical research purposes; multiple nucleotide sequence analysis for scientific research purposes; DNA sequence analysis for scientific research purposes; medical research services in the field of cell separation; medical research in the field of biologics;

GIPICA

The mark consists of the word of GIPICA in black and two circles connected to each other on the above the letter A, wherein the two connected circles have the designed portions in black, red and blue, and a white background color is not part of the mark.;Pharmaceutical preparations for the treatment of cancer cells; Cells for medical or clinical use; Pharmaceutical preparations for activating cellular function; Biological preparations for the treatment of immune system related disorders; Biological preparations for the treatment of cancer; Pharmaceutical preparations for immunity adjustment; Pharmaceutical preparations for regulating the immune system; Pharmaceutical preparations for tumor treatment; Vaccines; Pharmaceutical preparations for the treatment of cancers with T cells; Pharmaceutical preparations for the treatment of cancers with CAR-T cells;The color(s) black, red and blue is/are claimed as a feature of the mark.;Product development in the field of cell therapy; biomedical research services; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; product development, namely, biologics development; biological research and analysis; consultancy in the field of analysis of biology sequence processing for medical research purposes; multiple nucleotide sequence analysis for scientific research purposes; DNA sequence analysis for scientific research purposes; medical research services in the field of cell separation; medical research in the field of biologics;